Viewing Study NCT02660034


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2026-03-04 @ 1:34 AM
Study NCT ID: NCT02660034
Status: COMPLETED
Last Update Posted: 2021-12-06
First Post: 2016-01-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Participants With Advanced Solid Tumors
Sponsor: BeiGene
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dose Escalation View
None Dose Expansion View
None BGB-A317 View
None BGB-290 View
None Tislelizumab View
None Pamiparib View